PL3269721T3 - Bicykliczny związek pirydynowy - Google Patents
Bicykliczny związek pirydynowyInfo
- Publication number
- PL3269721T3 PL3269721T3 PL15884684T PL15884684T PL3269721T3 PL 3269721 T3 PL3269721 T3 PL 3269721T3 PL 15884684 T PL15884684 T PL 15884684T PL 15884684 T PL15884684 T PL 15884684T PL 3269721 T3 PL3269721 T3 PL 3269721T3
- Authority
- PL
- Poland
- Prior art keywords
- pyridine compound
- bicyclic pyridine
- bicyclic
- compound
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015046121 | 2015-03-09 | ||
| PCT/JP2015/083345 WO2016143200A1 (ja) | 2015-03-09 | 2015-11-27 | 二環式ピリジン化合物 |
| EP15884684.0A EP3269721B1 (en) | 2015-03-09 | 2015-11-27 | Bicyclic pyridine compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3269721T3 true PL3269721T3 (pl) | 2021-10-11 |
Family
ID=56880128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15884684T PL3269721T3 (pl) | 2015-03-09 | 2015-11-27 | Bicykliczny związek pirydynowy |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10023583B2 (pl) |
| EP (1) | EP3269721B1 (pl) |
| JP (1) | JP6646648B2 (pl) |
| KR (1) | KR102446212B1 (pl) |
| CN (1) | CN107428768B (pl) |
| AR (1) | AR102849A1 (pl) |
| AU (1) | AU2015386039B2 (pl) |
| BR (1) | BR112017018649B8 (pl) |
| CA (1) | CA2976746C (pl) |
| CO (1) | CO2017008372A2 (pl) |
| ES (1) | ES2869924T3 (pl) |
| IL (1) | IL254307B (pl) |
| MX (1) | MX370920B (pl) |
| MY (1) | MY198083A (pl) |
| PH (1) | PH12017501596B1 (pl) |
| PL (1) | PL3269721T3 (pl) |
| PT (1) | PT3269721T (pl) |
| RU (1) | RU2700411C2 (pl) |
| SG (1) | SG11201706745PA (pl) |
| TW (1) | TWI700285B (pl) |
| UA (1) | UA121889C2 (pl) |
| WO (1) | WO2016143200A1 (pl) |
| ZA (1) | ZA201706038B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210369654A1 (en) | 2018-10-16 | 2021-12-02 | Nippon Chemiphar Co., Ltd. | Agent for improving quality of sleep |
| WO2020080399A1 (ja) | 2018-10-17 | 2020-04-23 | 日本ケミファ株式会社 | 夜間多尿の治療又は予防剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006026832A1 (en) | 2004-09-09 | 2006-03-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Enzyme inhibitors and uses thereof |
| EP2029609A2 (en) * | 2006-06-08 | 2009-03-04 | Eli Lilly & Company | Novel mch receptor antagonists |
| EP2262797A4 (en) | 2007-11-19 | 2011-11-30 | Howard Florey Inst | INHIBITORS OF INSULIN-REGULATED AMINOPEPTIDASE (IRAP) AND THEIR APPLICATIONS |
| CN102209718A (zh) * | 2008-11-06 | 2011-10-05 | 安斯泰来制药株式会社 | 氨基甲酸酯化合物或其盐 |
| JP2013147430A (ja) * | 2010-04-28 | 2013-08-01 | Astellas Pharma Inc | 夜間頻尿の予防又は治療剤 |
| JP5888237B2 (ja) * | 2010-09-07 | 2016-03-16 | アステラス製薬株式会社 | ピラゾロキノリン化合物 |
| CA2878040A1 (en) * | 2012-07-11 | 2014-01-16 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| TWI647227B (zh) | 2013-02-28 | 2019-01-11 | 日商安斯泰來製藥股份有限公司 | ２－醯胺噻唑衍生物或其鹽 |
| CA2950259C (en) * | 2014-05-28 | 2022-08-23 | Astellas Pharma Inc. | Pyridine derivative for the treatment of nocturia |
-
2015
- 2015-11-26 AR ARP150103899A patent/AR102849A1/es unknown
- 2015-11-27 BR BR112017018649A patent/BR112017018649B8/pt active IP Right Grant
- 2015-11-27 JP JP2017504564A patent/JP6646648B2/ja active Active
- 2015-11-27 CN CN201580077585.XA patent/CN107428768B/zh active Active
- 2015-11-27 PL PL15884684T patent/PL3269721T3/pl unknown
- 2015-11-27 UA UAA201709737A patent/UA121889C2/uk unknown
- 2015-11-27 ES ES15884684T patent/ES2869924T3/es active Active
- 2015-11-27 KR KR1020177020910A patent/KR102446212B1/ko active IP Right Grant
- 2015-11-27 AU AU2015386039A patent/AU2015386039B2/en active Active
- 2015-11-27 MY MYPI2017703298A patent/MY198083A/en unknown
- 2015-11-27 US US15/551,222 patent/US10023583B2/en active Active
- 2015-11-27 MX MX2017010930A patent/MX370920B/es active IP Right Grant
- 2015-11-27 EP EP15884684.0A patent/EP3269721B1/en active Active
- 2015-11-27 TW TW104139686A patent/TWI700285B/zh active
- 2015-11-27 WO PCT/JP2015/083345 patent/WO2016143200A1/ja active Application Filing
- 2015-11-27 CA CA2976746A patent/CA2976746C/en active Active
- 2015-11-27 SG SG11201706745PA patent/SG11201706745PA/en unknown
- 2015-11-27 PT PT158846840T patent/PT3269721T/pt unknown
- 2015-11-27 RU RU2017134316A patent/RU2700411C2/ru active
-
2017
- 2017-08-16 CO CONC2017/0008372A patent/CO2017008372A2/es unknown
- 2017-09-04 IL IL254307A patent/IL254307B/en active IP Right Grant
- 2017-09-05 ZA ZA2017/06038A patent/ZA201706038B/en unknown
- 2017-09-05 PH PH12017501596A patent/PH12017501596B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261551B (en) | bicyclic compounds | |
| ZA201902232B (en) | Pyridine compound | |
| ZA201701210B (en) | Substituted bicyclic compounds | |
| HK1255832A1 (zh) | 吡喃並二吡啶化合物 | |
| HK1256022A1 (zh) | 唑類取代的吡啶化合物 | |
| HK1252614A1 (zh) | 二環化合物 | |
| GB201521524D0 (en) | Compound | |
| EP3366674A4 (en) | PYRIDINE COMPOUND | |
| ZA201701783B (en) | Pyridine compounds | |
| DK3330264T3 (en) | Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal | |
| ZA201706038B (en) | Bicyclic pyridine compound | |
| GB201518950D0 (en) | Compound | |
| HK1251574A1 (zh) | 四氫噁庚英吡啶化合物 | |
| GB201520393D0 (en) | Compound | |
| GB201520391D0 (en) | Compound | |
| GB201509303D0 (en) | Compound |